Samsung Bio is bringing its financial hot streak into 2026, with no signs of stopping—save for a potential worker strike ...
The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained ...
As pharma giants slash headcounts and routinely strike billion-dol | Amid industry layoffs and M&A headlines, Big Pharma's ...
Novartis is running a new disease awareness campaign for Sjögren's syndrome with help from dancer, choreographer, and TV personality Carrie Ann Inaba. | Novartis is running a new disease awareness ...
Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso, a combination ...
Pfizer’s chief strategist Andrew Baum, M.D., is leaving his post two years after pivoting from a career-long tenure as a ...
After prevailing in two kidney cancer trials in the refractory and early-stage settings, Merck & Co.’s blockbuster prospect ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift ...
The era of off-label guesswork for patients living with the rare autoimmune disorder MOGAD may soon be over, as a phase 3 ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...
Already approved to treat four rare diseases, AstraZeneca’s Ultomiris has shown its ability against another rare disorder, ...
Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease that can cause muscle weakness, fatigue and problems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results